These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3693873)

  • 1. Myoclonic movements as a side-effect of treatment with therapeutic doses of clomipramine.
    Casas M; Garcia-Ribera C; Alvarez E; Udina C; Queralto JM; Grau JM
    Int Clin Psychopharmacol; 1987 Oct; 2(4):333-6. PubMed ID: 3693873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clomipramine: plasma levels, side effects and outcome in obsessive-compulsive neurosis.
    Stern RS; Marks IM; Wright J; Luscombe DK
    Postgrad Med J; 1980; 56 Suppl 1():134-9. PubMed ID: 7393824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma concentration of clomipramine and desmethylclomipramine and clinical response in depressed patients.
    Montgomery SA; McAuley R; Montgomery DB; Dawling S; Braithwaite RA
    Postgrad Med J; 1980; 56 Suppl 1():130-3. PubMed ID: 7393823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steady-state plasma levels of clomipramine and its metabolites: impact of the sparteine/debrisoquine oxidation polymorphism. Danish University Antidepressant Group.
    Nielsen KK; Brøsen K; Gram LF
    Eur J Clin Pharmacol; 1992; 43(4):405-11. PubMed ID: 1451721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clinical trial of a 50 mg formulation of clomipramine (Anafranil) with steady-state plasma level measurements.
    Gringras M; Luscombe DK; Jones RB; Beaumont G; Seldrup J; John V
    J Int Med Res; 1977; 5(1 Suppl):119-24. PubMed ID: 863081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clomipramine in obsessive-compulsive ritualisers treated with exposure therapy: relations between dose, plasma levels, outcome and side effects.
    Kasvikis Y; Marks IM
    Psychopharmacology (Berl); 1988; 95(1):113-8. PubMed ID: 3133689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma concentrations of clomipramine and desmethylclomipramine in obsessive-compulsive neurosis.
    Luscombe DK; Wright J; Stern RS; Mawson D; Marks IM
    Postgrad Med J; 1980; 56 Suppl 1():140-3. PubMed ID: 7393825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship of plasma clomipramine and N-desmethylclomipramine to response in obsessive-compulsive disorder.
    Mavissakalian M; Jones B; Olson S; Perel JM
    Psychopharmacol Bull; 1990; 26(1):119-22. PubMed ID: 2371366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma levels and clinical improvement--a comparative study of clomipramine and amitriptyline in depression.
    Moyes IC; Ray RL; Moyes RB
    Postgrad Med J; 1980; 56 Suppl 1():127-9. PubMed ID: 7393822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationships between clinical response, plasma levels and side-effects of clomipramine (Anafranil) in general practitioner trials.
    Miller P; Luscombe DK; Jones RB; Seldrup J; Beaumont G; John V
    J Int Med Res; 1977; 5(1 Suppl):108-18. PubMed ID: 863079
    [No Abstract]   [Full Text] [Related]  

  • 11. Preliminary observations of the significance of monitoring tricyclic antidepressant plasma levels in the pediatric patient.
    Dugas M; Zarifian E; Leheuzey MF; Rovei V; Durand G; Morselli PL
    Ther Drug Monit; 1980; 2(4):307-14. PubMed ID: 7222184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clomipramine and desmethylclomipramine: relationship between plasma levels and clinical effect (author's transl)].
    Vandel B; Vandel S; Jounet JM; Allers G; Volmat R
    Encephale; 1981; 7(5):601-8. PubMed ID: 7327152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical response and tricyclic plasma levels during treatment with clomipramine.
    Della Corte L; Broadhurst AD; Sgaragli GP; Filippini S; Heeley AF; James HD; Faravelli C; Pazzagli A
    Br J Psychiatry; 1979 Apr; 134():390-400. PubMed ID: 444789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variation in plasma concentrations of clomipramine and desmethylclomipramine during clomipramine therapy.
    Hullin RP
    Postgrad Med J; 1980; 56 Suppl 1():117-9. PubMed ID: 7190279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relating plasma levels of clomipramine and clinical response.
    Seldrup J
    J Int Med Res; 1980; 8 Suppl 3():96-110. PubMed ID: 7202825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clomipramine and exposure for compulsive rituals: II. Plasma levels, side effects and outcome.
    Stern RS; Marks IM; Mawson D; Luscombe DK
    Br J Psychiatry; 1980 Feb; 136():161-6. PubMed ID: 7370482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clomipramine in the elderly: tolerance and plasma levels.
    Kunik ME; Pollock BG; Perel JM; Altieri L
    J Geriatr Psychiatry Neurol; 1994; 7(3):139-43. PubMed ID: 7916936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of plasma levels of clomipramine, its hydroxylated and desmethylated metabolites: prediction of clinical outcome in mood disorders using discriminant analysis of therapeutic drug monitoring data.
    Noguchi T; Shimoda K; Takahashi S
    J Affect Disord; 1993 Dec; 29(4):267-79. PubMed ID: 8126313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug monitoring of clomipramine and desmethylclomipramine in depressed patients using a new liquid chromatographic assay.
    Diquet B; Thomaré P; Bocquentin M; Diviné C
    Biomed Chromatogr; 1993; 7(2):59-63. PubMed ID: 8485374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of clomipramine during pregnancy.
    Ter Horst PG; Proost JH; Smit JP; Vries MT; de Jong-van de Berg LT; Wilffert B
    Eur J Clin Pharmacol; 2015 Dec; 71(12):1493-500. PubMed ID: 26416100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.